Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 596 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07792954RecruitingPhase 3
Weekly weight-loss study for Chinese adults with overweight or obesity
This study tests a once-weekly medicine called PF-08653944 to see if it helps Chinese adults lose weight compared to a placebo (a pill with no active medicine). It may be an option if you have been unable to lose weight through diet alone.
Hefei, AnhuiAges 18 years+ - NCT07071519RecruitingPhase 3
Risankizumab for young people with ulcerative colitis
This study tests risankizumab (a medication that targets inflammation) in young people with ulcerative colitis who haven't improved enough on other treatments. It aims to see if risankizumab can help control symptoms and reduce bowel inflammation.
Phoenix, ArizonaAges 2–17 - NCT07444450RecruitingPhase 3
Study of salanersen for babies with SMA previously treated with gene therapy
This study tests a new medicine called salanersen in babies who have already received gene therapy for SMA. It aims to see if adding salanersen is safe and effective.
Flower Mound, TexasAges birth–7 months - NCT07794761RecruitingPhase 3
Weekly injection for weight loss in adults with obesity in Japan
This study tests a once-weekly injection called berobenatide to see if it helps adults with obesity lose weight and improve related health problems like high blood pressure, high cholesterol, or blood sugar issues. It is for people living in Japan.
Chiba, ChibaAges 18 years+ - NCT06703606RecruitingPhase 1
Switching from Emicizumab to Marstacimab for Severe Hemophilia A
This study tests if switching from emicizumab to a new medicine called marstacimab is safe and effective for people with severe hemophilia A. You must have been on emicizumab for at least 6 months and not have a history of blood clots or heart disease.
La Jolla, CaliforniaAges 12–74 - NCT07845500RecruitingPhase 3
Monthly shot to help keep weight off after switching from semaglutide or tirzepatide
This study tests a new once-a-month medicine for people who have already been taking a weight-loss medication and want to keep the weight off. Participants will switch from their current medicine (semaglutide or tirzepatide) to the study drug.
Birmingham, AlabamaAges 18 years+ - NCT06679140RecruitingPhase 3
Study of Ibuzatrelvir for COVID-19 in high-risk patients
This trial tests if a new medicine called ibuzatrelvir can help people with COVID-19 who have certain health risks avoid severe illness. It is for patients who cannot or choose not to take another COVID-19 pill called Paxlovid.
Huntsville, AlabamaAges 12 years+ - NCT07765888RecruitingPhase 3
Tilrekimig for moderate-to-severe eczema
This study tests an investigational medicine called Tilrekimig for people with moderate-to-severe eczema (atopic dermatitis) that hasn't improved with standard treatments. It aims to see if the medicine can reduce symptoms and improve quality of life.
Birmingham, AlabamaAges 12 years+ - NCT07029828RecruitingPhase 3
Long-term study of ritlecitinib for severe alopecia areata in children
This study tests a medicine called ritlecitinib for children with severe alopecia areata (a condition causing hair loss). It is for kids who have already completed a previous study of this medicine to see how well it works and how safe it is over a longer period.
Irvine, CaliforniaAges 6–14 - NCT06462235RecruitingPhase 2
Testing a new antibiotic for hospitalized babies with infection
This study tests a new antibiotic called aztreonam-avibactam (ATM-AVI) for treating serious bacterial infections in hospitalized babies under 9 months old. The goal is to see if it's safe and works well.
Orange, CaliforniaAges Up to 9 months - NCT04749927Recruiting
Image-based eye photos to study heart blood-vessel risks
This study uses deep learning (computer pattern recognition) to analyze retinal photos (pictures of the eye’s blood vessels). It aims to link what’s seen in the eye to heart and blood-vessel disease patterns, especially in people with higher cardiovascular risk.
SeoulAges 20–79 - NCT04060706Recruiting
Testing new computer tools for radiation treatment planning
This study tests how well new computer methods (called algorithms and machine learning) can support radiation therapy decisions. You might benefit by helping improve how radiation is planned and checked, especially for cancers treated with curative-intent therapy.
Cambridge, CambridgeshireAges 18 years+ - NCT05426135Recruiting
AI tool to assess cancer risk and guide care
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
Wuhan, HubeiAges 18–75 - NCT05614193Recruiting
Deep imaging study for suspected stroke patients
This trial studies an advanced way to analyze CT or MRI scans for people who may have had a stroke or reduced blood flow to the brain. It aims to improve how scans are interpreted and shared for better care.
Beijing, Beijing MunicipalityAges 18–100 - NCT04558112RecruitingPhase 2
Levodopa for improving learning in PTSD
This study tests whether a medicine called levodopa, combined with brain imaging, can help improve learning and memory in people with PTSD. The goal is to see if it can help you better process trauma-related thoughts and improve your quality of life.
Austin, TexasAges 21–50 - NCT05732974Recruiting
Using a computer tool to find lung cancer relapse risk
This study uses a machine-learning computer method to identify people with early-stage lung cancer who have a higher risk of the cancer coming back after surgery. If you qualify, your information may help researchers improve how doctors predict relapse and plan follow-up care.
ToulouseAges 18 years+ - NCT06113042Recruiting
Kids lifestyle program for kindergarten families
This study tests a lifestyle modification program for kindergarten children and their parents to encourage healthy habits. It is for families in participating kindergartens who can speak Cantonese and read Chinese.
Hong KongAges 3 years+ - NCT07869043RecruitingPhase 3
Study of tilrekimig for people with severe asthma
This study tests an investigational medicine called tilrekimig for people with severe asthma that is not well controlled. The goal is to see if it can reduce asthma attacks and improve breathing.
Pittsburgh, PennsylvaniaAges 12–80 - NCT06144203Recruiting
Exercise effects on fear learning in PTSD
This study explores whether aerobic exercise helps people with or without PTSD better learn to overcome fear. You will do exercise and have brain scans (MRI) to see how your brain processes fear.
Tuscaloosa, AlabamaAges 18–64 - NCT07870382Enrolling by invitation
Learning muscle activation methods in healthy students
This study tests different ways to help healthy young adults learn how to activate their muscles. It aims to see which learning technique works best for improving muscle control.
Konya, KonyaAges 18–35 - NCT07870460Recruiting
Predicting training participation in youth football players
This study uses wearable sensors and machine learning to understand why some elite youth football players reduce their training participation. It aims to help coaches and medical staff better support players.
OlomoucAges 15–19 - NCT06285084Recruiting
Deep learning ECG test for sports eligibility
This trial uses a deep learning computer program to analyze your heart's electrical activity (ECG) during a routine check-up. It aims to help doctors decide if it's safe for you to play competitive sports.
Milan, LombardyAges 18–60 - NCT06364670Recruiting
Acupuncture for tinnitus: brain imaging study
This study is testing whether acupuncture can help treat tinnitus by using a special brain imaging technique (fNIRS) to see how the brain responds. It may help find out who benefits most from acupuncture.
Hangzhou, ZhejiangAges 18–60 - NCT07835256Recruiting
Virtual reality training for rheumatology staff
This trial tests a training program that combines online learning with virtual reality to help healthcare providers in rheumatology improve their skills. It may benefit patients by ensuring their care team is well-trained in managing rheumatic conditions.
Leiden, South HollandAges 18 years+
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 596 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.